Outsourcing Storage Demand Drives Vindon Scientific Investments

By Dan Stanton

- Last updated on GMT

Related tags: Pharma companies, Pharmaceutical industry, Pharmacology

Vindon trebles capacity at its stability storage facility
Vindon trebles capacity at its stability storage facility
Vindon says its investments in its Irish and Californian facilities come as pharma companies shift to outsourcing stability storage in order to save costs.

According to Vindon Scientific’s Director Patrick Jackson, the company, keen on “establishing strategic alliances,”​ will up capacity at its IMB (Irish Medicine's Board) certified, GMP compliant storage facility in County Waterford, Ireland to 350m3​.

Vindon, headquartered in the UK, offers clients stability storage, freezer storage and -80°C Ultra-low temperature storage, servicing the pharmaceutical and biopharmaceutical R&D industry.

Jackson, speaking with Outsourcing-Pharma.com, said that though Ireland’s pharmaceutical industry has seen a number of ups and downs in the last few years, Vindon is “seeing an increase in the amount of outsourcing in our particular area as pharma companies are looking at ways of reducing costs.”

“Virtually all of the major pharma companies are watching their revenues decrease because of weak pipelines, patent expirations, and the rise of generics,” ​he said. “We see these companies more actively seeking outsourcing partners.”

Jackson added: “It makes economic sense to outsource stability storage as development comes in peaks and troughs so the storage requirements are the same, therefore they only pay for the service when required.”

According to the Irish Industrial Development Agency (IDA), nine of the top ten global pharmaceutical companies have operations in Ireland. Though economic pressures have seen facility divestitures and job cuts by industry giant Merck & Co.​ and Pfizer​, R&D is still a major market, with Irish CRO (contract research organization) Icon​ telling this publication recently that the trend towards outsourcing is set to continue.

Expansion Across the Pond

It is not only Ireland that is seeing an increase in need of storage solutions as Vindon has also announced it will be opening a facility in Orange County to serve the pharma and biopharma industries in California.

The suite – set to be completed mid-2013 - will be the second for Vindon in the States and, according to Jackson will provide “storage at ICH and custom conditions whilst also providing DEA storage with our partner CRO’s.”

Related news

Related product

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us


View more